Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population
NCT01663805
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Delayed Function of Renal Transplant
Interventions
DRUG:
Everolimus
Sponsor
MARIO ABBUD FILHO